4M Therapeutics
PrivateLast Round
Seed
Aug 28, 2025
Total Funding Raised
$4.12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
4M Therapeutics operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Seed round in August 2025.
4M Therapeutics is a biotechnology company that develops targeted therapies for neuropsychiatric and neurodegenerative conditions using a proprietary human brain cell platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4M Therapeutics Comparables
Compare 4M Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cogentis Therapeutics | 89% | |
| AMO Pharma | 80% | |
| Autobahn Therapeutics | 76% |
For institutional investors. Book with your work email.
4M Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 28, 2025 | ||||
| Grant | Nov 12, 2024 | ||||
| Pre Seed | Aug 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
4M Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LvlUp Ventures | Pre Seed |
| Harvard Alumni Entrepreneurs | Pre Seed |
| SynGAP Research Fund | Grant, Pre Seed |
| Endless Frontier Labs | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 36% MoM.
- Jan 21, 2026
Monthly visitors grew 126% MoM, reaching 2.9K.
For institutional investors. Book with your work email.
4M Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 4M Therapeutics's valuation, stock price, and market status.
Is 4M Therapeutics a public or private company?
4M Therapeutics is a private company.
What is the current stock price of 4M Therapeutics?
4M Therapeutics is a private company, so its shares have no public market price. Caplight tracks 4M Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 4M Therapeutics worth (valuation)?
Valuation information for 4M Therapeutics is not publicly available.
Can I buy 4M Therapeutics stock?
4M Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 4M Therapeutics's last funding round?
4M Therapeutics's most recent funding round was Seed on August 28, 2025.
Who are the main investors in 4M Therapeutics?
Key investors in 4M Therapeutics include LvlUp Ventures, Harvard Alumni Entrepreneurs, SynGAP Research Fund, Endless Frontier Labs.
Will 4M Therapeutics IPO soon?
No public IPO plans have been announced for 4M Therapeutics.
How can I track 4M Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in 4M Therapeutics's shares on secondary markets.